These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4022264)

  • 1. S(+)Apomorphines. Selective inhibition of excitatory effects of dopamine injected into the limbic system of the rat.
    Campbell A; Baldessarini RJ; Teicher MH; Neumeyer JL
    Neuropharmacology; 1985 May; 24(5):391-9. PubMed ID: 4022264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective antidopaminergic effects of S(+)N-n-propylnoraporphines in limbic versus extrapyramidal sites in rat brain: comparisons with typical and atypical antipsychotic agents.
    Campbell A; Yeghiayan S; Baldessarini RJ; Neumeyer JL
    Psychopharmacology (Berl); 1991; 103(3):323-9. PubMed ID: 1676180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of isomers of apomorphines on dopamine receptors in striatal and limbic tissue of rat brain.
    Kula NS; Baldessarini RJ; Bromley S; Neumeyer JL
    Life Sci; 1985 Sep; 37(11):1051-7. PubMed ID: 4033350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system.
    Campbell A; Baldessarini RJ; Kula NS; Ram VJ; Neumeyer JL
    Brain Res; 1987 Feb; 403(2):393-7. PubMed ID: 3828830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-n-propyl-norapomorphine: an extremely potent stimulant of dopamine autoreceptors.
    Argiolas A; Mereu G; Serra G; Melis MR; Fadda F; Gessa GL
    Brain Res; 1982 Jan; 231(1):109-16. PubMed ID: 6799148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of apomorphine isomers in the rat: selective locomotor-inhibitory effects of S(+)N-n-propylnorapomorphine.
    Campbell A; Baldessarini RJ; Teicher MH; Neumeyer JL
    Psychopharmacology (Berl); 1986; 88(2):158-64. PubMed ID: 3081927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
    Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of limbic and extrapyramidal actions of intracerebrally injected dopamine by ergolines with partial D2 agonist activity in the rat.
    Campbell A; Baldessarini RJ; Yeghiayan S
    Brain Res; 1992 Oct; 592(1-2):348-52. PubMed ID: 1360315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desenkephalin-gamma-endorphin is an antagonist of the hyperactivity response induced by infusion of dopamine into the nucleus accumbens of rat and ventral striatum of marmoset.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1989 Nov; 28(11):1223-9. PubMed ID: 2574424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections.
    Costall B; Domeney AM; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):27-33. PubMed ID: 6633677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat.
    Campbell A; Baldessarini RJ; Gao Y; Zong R; Neumeyer JL
    Neuropharmacology; 1990 Jun; 29(6):527-36. PubMed ID: 1974710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens.
    Johnels B
    Pharmacol Biochem Behav; 1982 Aug; 17(2):283-9. PubMed ID: 7134238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic apomorphine reverses intrastriatal dopamine-induced contralateral deviation.
    Joyce JN; Davis RE; Van Hartesveldt C
    Eur J Pharmacol; 1983 Feb; 87(2-3):283-9. PubMed ID: 6840191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F; Ettenberg A; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
    Barnes JM; Barnes NM; Costall B; Naylor RJ
    Neuropharmacology; 1990 Apr; 29(4):327-36. PubMed ID: 1971430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic function.
    Hirsch SR; Richardson-Andrews R; Costall B; Kelly ME; de Belleroche J; Naylor RJ
    Psychopharmacology (Berl); 1987; 93(1):101-4. PubMed ID: 2819921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.